Educational Events & Programs
NCCN Oncology Policy Program
The NCCN Oncology Policy Program was initiated in 2009 to allow opportunities for discussion among oncology stakeholders to address relevant health policy concerns. The NCCN Oncology Policy Program has convened Policy Summits in areas such as comparative effectiveness research (CER), risk evaluation and mitigation strategies (REMS), patient advocacy, off-label drug use and compendia, biosimilars, molecular testing, clinical pathways, and data needs.
NCCN will continue this initiative in 2014 with summits focused on current policy topics. Details on NCCN's 2014 policy programs, as well as past summits, can be found below.
Please send any comments or questions regarding the NCCN Oncology Policy Program to email@example.com.
Monday, November 3, 2014 • Washington, DC
NCCN will be hosting its’ 5th annual Patient Advocacy Summit, Patient Concerns in 2014 – Big Data, Access, and Palliative Care, on November 3, 2014 at the National Press Club in Washington, DC. Patients today are facing a variety of concerns and considerations when confronting cancer. From the plethora of data they encounter when making treatment decisions to accessing and paying for drugs and biologics to palliative care, patients need resources to help them make appropriate care and financial decisions.Find out more.
F. Marc Stewart, MD, Seattle Cancer Care Alliance, discusses the physician perspective on the Physician Payments Sunshine Act at the NCCN Policy Summit: The Impact of Health Care Reform on Academic Oncology Practice that took place on July 10, 2014. View recording here.
July 2014 • Arlington, VA
April 2014 • Bethesda, MD
White Paper Coming Soon!